Phase 2 Study of Ponatinib in Patients (Pts) with Advanced Gastrointestinal Stromal Tumors (Gist) After Failure of Tyrosine Kinase Inhibitor (Tki) Therapy: Early Results

Authors
Category Primary study
JournalAnnals of Oncology
Year 2014
This article has no abstract
Epistemonikos ID: 3053ce8b28226e2ef70098856c84b416cdd7e6fd
First added on: Feb 19, 2025